Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4B | Q07343 | 6/20 | 0.36 |
| ▸ | PDE4C | Q08493 | 6/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | POLQ | O75417 | 1/20 | 0.35 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.34 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10189362 | 0.97 | ALDH1A1 (0.38) | ALDH1A1HPGDHSD17B10SMN1; SMN2KDM4E | |
| SCHEMBL10189356 | 0.90 | POLB (0.41) | ALDH1A1HPGDHSD17B10SMN1; SMN2KDM4E | |
| SCHEMBL10189364 | 0.90 | ALDH1A1 (0.40) | ALDH1A1HPGDHSD17B10SMN1; SMN2KDM4E | |
| SCHEMBL13390055 | 0.90 | RXFP1 (0.39) | PDE4BPDE4CALDH1A1HPGDHSD17B10 | |
| SCHEMBL616279 | 0.87 | RXFP1 (0.41) | ALDH1A1HPGDHSD17B10SMN1; SMN2KDM4E | |
| SCHEMBL10188926 | 0.84 | ALDH1A1 (0.44) | ALDH1A1HPGDHSD17B10SMN1; SMN2KDM4E | |
| SCHEMBL12339118 | 0.83 | MEN1 (0.36) | PDE4BPDE4CALDH1A1HPGDHSD17B10 | |
| SCHEMBL13718042 | 0.82 | RXFP1 (0.40) | ALDH1A1HPGDHSD17B10SMN1; SMN2KDM4E | |
| SCHEMBL10189358 | 0.82 | NPSR1 (0.46) | ALDH1A1HPGDHSD17B10SMN1; SMN2KDM4E | |
| SCHEMBL10189353 | 0.81 | LTB4R (0.39) | ALDH1A1HPGDHSD17B10SMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130203824-A1 | COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS | SUN LIJUN (US) | 2013-08-08 | — | — | US | disclosed |
| US-8399435-B2 | Compounds for the treatment of proliferative disorders | SYNTA PHARMACEUTICALS CORP. (US) | 2013-03-19 | — | — | US | disclosed |
| US-20120040937-A1 | COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS | SYNTA PHARMACEUTICALS CORP. | 2012-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120040937-A1 | COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS | RB1, MKI67, MAPRE1 | PDE4B 1726/4885PDE4C 2685/4885ALDH1A1 1872/4885 |
| US-20130203824-A1 | COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS | RB1, MKI67, MAPRE1 | PDE4B 1726/4885PDE4C 2685/4885ALDH1A1 1872/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.